Eli Lilly & Co. named David Ricks president, Lilly USA. Ricks, who heads the company’s China division, will replace Enrique Conterno, who was recently appointed head of Lilly’s new diabetes business unit.
 
IMS Health named Donald Otterbein general manager, business transformation services. Otterbein is responsible for leading growth in commercial analytics outsourcing of pharma clients’ sales, marketing and managed markets activities, and reports to chairman and CEO David Carlucci.